These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37415169)

  • 21. Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.
    Strupat C; Shigute Z; Bedi AS; Rieger M
    PLoS One; 2022; 17(3):e0264633. PubMed ID: 35239711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.
    Post LA; Argaw ST; Jones C; Moss CB; Resnick D; Singh LN; Murphy RL; Achenbach CJ; White J; Issa TZ; Boctor MJ; Oehmke JF
    J Med Internet Res; 2020 Nov; 22(11):e24248. PubMed ID: 33211026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs.
    Qunaibi EA; Helmy M; Basheti I; Sultan I
    Elife; 2021 May; 10():. PubMed ID: 34042047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
    Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
    Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal changes in COVID-19 vaccination intent among South African adults: evidence from the NIDS-CRAM panel survey, February to May 2021.
    Burger R; Köhler T; Golos AM; Buttenheim AM; English R; Tameris M; Maughan-Brown B
    BMC Public Health; 2022 Mar; 22(1):422. PubMed ID: 35236319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 vaccination coverage in Egypt: a large-scale national survey - to help achieving vaccination target, March-May, 2022.
    Kandeel A; Eldeyahy I; Abu ElSood H; Fahim M; Afifi S; Abu Kamar S; BahaaEldin H; Ahmed E; Mohsen A; Abdelghaffar K
    BMC Public Health; 2023 Feb; 23(1):397. PubMed ID: 36849954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 vaccine acceptance, hesitancy, and determinants among physicians in a university-based teaching hospital in Thailand.
    Sirikalyanpaiboon M; Ousirimaneechai K; Phannajit J; Pitisuttithum P; Jantarabenjakul W; Chaiteerakij R; Paitoonpong L
    BMC Infect Dis; 2021 Nov; 21(1):1174. PubMed ID: 34809607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cross sectional study to examine factors influencing COVID-19 vaccine acceptance, hesitancy and refusal in urban and rural settings in Tamil Nadu, India.
    Joshi A; Surapaneni KM; Kaur M; Bhatt A; Nash D; El-Mohandes A
    PLoS One; 2022; 17(6):e0269299. PubMed ID: 35679313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 vaccine hesitancy among non-refugees and refugees in Kenya.
    Rego RT; Ngugi AK; Sophie Delius AJ; Luchters S; Kolars JC; Irfan FB; Weinheimer-Haus E; Abubakar A; Shah R; Zhu J; Boulton ML; Hofer T; Waljee AK
    PLOS Glob Public Health; 2022; 2(8):e0000917. PubMed ID: 36962839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis.
    Ackah M; Ameyaw L; Gazali Salifu M; Afi Asubonteng DP; Osei Yeboah C; Narkotey Annor E; Abena Kwartemaa Ankapong E; Boakye H
    PLoS One; 2022; 17(5):e0268711. PubMed ID: 35584110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling.
    Muhajarine N; Adeyinka DA; McCutcheon J; Green KL; Fahlman M; Kallio N
    PLoS One; 2021; 16(11):e0259513. PubMed ID: 34767603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining confidence and hesitancy towards COVID-19 vaccines: A cross-sectional survey using in-person data collection in rural Ghana.
    Afreh OK; Angwaawie P; Attivor E; Boateng LA; Brackstone K; Head MG; Manyeh AK; Vidzro G
    Vaccine; 2023 Mar; 41(13):2113-2119. PubMed ID: 36822965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sociodemographic predictors of COVID-19 vaccine hesitancy and leading concerns with COVID-19 vaccines among pregnant women at a South Texas clinic.
    Sutanto MY; Hosek MG; Stumpff SK; Neuhoff BK; Hernandez BS; Wang Z; Ramsey PS; Boyd AR
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10368-10374. PubMed ID: 36195447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with COVID-19 vaccine hesitancy among healthcare workers in Cameroon and Nigeria: a web-based cross-sectional study.
    Aseneh JB; Agbor VN; Kadia BM; Okolie EA; Ofomata CJ; Etombi CL; Ekaney DSM; Joko Fru YW
    Int Health; 2023 Nov; 15(6):702-714. PubMed ID: 36905293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acceptance of COVID-19 vaccination at different hypothetical efficacy and safety levels in ten countries in Asia, Africa, and South America.
    Rosiello DF; Anwar S; Yufika A; Adam RY; Ismaeil MI; Ismail AY; Dahman NB; Hafsi M; Ferjani M; Sami FS; Monib FA; Subramaniam R; Anandu S; Haque MA; Ferreto LE; Aburto JT; Rojas JE; Enitan SS; Yomi AR; Ezigbo ED; Babadi E; Kakemam E; Malik NI; Ullah I; Sallam M
    Narra J; 2021 Dec; 1(3):e55. PubMed ID: 38450212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel adaptation of spatial interpolation methods to map health attitudes related to COVID-19.
    Behal R; Davis K; Doering J
    BMC Proc; 2023 Jul; 17(Suppl 7):17. PubMed ID: 37461011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sociodemographic predictors of and main reasons for COVID-19 vaccine hesitancy in eastern Oslo: a cross-sectional study.
    Steinmetz L
    BMC Public Health; 2022 Oct; 22(1):1878. PubMed ID: 36207702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 vaccine hesitancy and attitudes in Qatar: A national cross-sectional survey of a migrant-majority population.
    Alabdulla M; Reagu SM; Al-Khal A; Elzain M; Jones RM
    Influenza Other Respir Viruses; 2021 May; 15(3):361-370. PubMed ID: 33605010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review.
    Deml MJ; Githaiga JN
    BMJ Open; 2022 Nov; 12(11):e066615. PubMed ID: 36400736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.